Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Plos One|March 7, 2019
FBXO7 sensitivity of phenotypic traits elucidated by a hypomorphic alleleCarmen Ballesteros Reviriego, Simon Clare, Mark J Arends, et al.Nutrients|April 3, 2021
Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring CohortAntonio Gázquez, María J Giménez-Bañón, María T Prieto-Sánchez, et al.Cancer Immunology, Immunotherapy : CII|November 29, 2022
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA studyAnn W Silk, Steven J O'Day, Howard L Kaufman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 TherapyMelinda L Telli, Hiroshi Nagata, Irene Wapnir, et al.Annals of Nutrition & Metabolism|June 4, 2023
Serum Vitamins A and E at Mid-Pregnancy and Their Relationships with Both Maternal and Cord Blood Antioxidant Status and Perinatal Conditions: The NELA CohortMaría Sánchez-Campillo, Antonio Gázquez, Ana Serrano-Munuera, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2020
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent MelanomaAlain P Algazi, Christopher G Twitty, Katy K Tsai, et al.Rheumatology (Oxford, England)|September 25, 2010
The lupus family registry and repositoryAstrid Rasmussen, Sydney Sevier, Jennifer A Kelly, et al.Nature Immunology|December 18, 2019
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variationLucie Abeler-Dörner, Adam G Laing, Anna Lorenc, et al.Journal for Immunotherapy of Cancer|December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.Cancers|January 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.Pageof 6